Table 1.
Baseline characteristics of the population
| Baseline characteristics | n=157 |
|---|---|
| Male, n (%) | 91 (58.0) |
| Age (years) | 67.4±8.9 |
| BMI (Kg/m²) | 25.0±3.4 |
| Paroxysmal AF, n (%) | 43 (27.4) |
| Persistent AF, n (%) | 114 (72.6) |
| CHA2DS2-VASc score | 3.06±1.06 |
| HAS-BLED score | 2.78±0.81 |
| Medical history | |
| Hypertension, n (%) | 109 (69.4) |
| Heart failure, n (%) | 73 (46.5) |
| Diabetes mellitus, n (%) | 38 (24.2) |
| Stroke history, n (%) | 46 (29.3) |
| Coronary heart disease, n (%) | 35 (22.3) |
| Abnormal liver function, n (%) | 31 (19.7) |
| Abnormal rennal function, n (%) | 4 (2.5) |
| Hemorrhage history, n (%) | 5 (3.2) |
| Medications | |
| Antiplatelet agents, n (%) | 35 (22.3) |
| Oral anticoagulants, n (%) | 96 (61.1) |
| Warfarin, n (%) | 27 (17.2) |
| New oral anticoagulants, n (%) | 69 (43.9) |
Data represented as N (%) or mean ± standard deviation. BMI: body mass index, AF: atrial fibrillation